Stigma
Validation of MDR-TB stigma scale for use in patients with multidrug-resistant tuberculosis (MDR-TB) (Stigma A)
STUDY SITE: Ha Noi
COMPLETED: 2022
PROJECT IMPLEMENTER: Hanoi Lung Hospital
FUNDED BY: The University of Sydney
CORE STAKEHOLDERS:
National Lung Hospital
Hanoi Lung Hospital
AUSTRALIAN PRINCIPAL INVESTIGATOR: Professor Greg Fox, The University of Sydney and the Woolcock Institute
OBJECTIVES:
Primary Objective:
To develop and validate a new MDR-TB stigma scale for use in patients.
Secondary Objectives:
To quantify the stigma of MDR-TB patients using a validated stigma scale (the Redwood MDR-TB Stigma Scale)
To compare the new Redwood MDR-TB stigma scale to the Explanatory Model Interview Catalogue (EMIC) MDR-TB stigma scale
Comparison of Stigma between New TB patients and MDR-TB Patients using the EMIC stigma scale (Stigma B)
STUDY SITE: Ha Noi
TIMELINE: 2018 - 2021
PROJECT IMPLEMENTER: Hanoi Lung Hospital
FUNDED BY: The University of Sydney
CORE STAKEHOLDERS:
National Lung Hospital
Hanoi Lung Hospital
AUSTRALIAN PRINCIPAL INVESTIGATOR: Professor Greg Fox, The University of Sydney and the Woolcock Institute
OBJECTIVES:
Primary Objective:
To establish the difference between the stigma reported by patients with MDR-TB and newly diagnosed TB.
Secondary Objectives:
To re-validate the EMIC TB stigma scale in the Vietnamese context
To re-validate the EMIC TB stigma scale for use in MDR-TB patients
To quantify stigma in MDR-TB patients
A quantify stigma in new TB patients
To compare the Redwood MDR-TB Stigma Scale to the EMIC TB stigma scale
Publications
Adaptation and validation of the Van Rie tuberculosis stigma scale in Vietnam, International Journal of Infectious Diseases
Depression, stigma and quality-of-life in people with drug-susceptible TB and drug-resistant TB in Vietnam, The International Journal of Tuberculosis and Lung Disease
Psychometric evaluation of a new drug-resistant tuberculosis stigma scale, Journal of Clinical Epidemiology